Yarrow Bioscience, Inc. (YARW): Total Liabilities
$2.40M
As of 2025-12-31
$1.54M
As of 2026-06-30
-36.5%
3-year compound annual growth
-46.8%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.40M | -83.8% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $14.82M | +65.6% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $8.95M | -4.2% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $9.35M | -49.2% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $18.41M | -67.3% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $56.25M | -11.5% | 2022-03-17, Balance as of period end |
| 2019-12-31 | $63.58M | +565.7% | 2021-03-04, Balance as of period end |
| 2018-12-31 | $9.55M | -34.5% | 2020-03-03, Balance as of period end |
| 2017-12-31 | $14.57M | +16.7% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $12.49M | n/a | 2018-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $2.40M | -83.8% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $69.14M | +0.8% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $5.08M | -14.4% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $754.4K | +74.3% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $140.38M | +6.8% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $1.61M | +19.2% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
Compare YARW, SLN, ELAB, VCNX side by side · Screen every company in Pharmaceutical Preparations ↗